| Not Yet Recruiting | Study to Evaluate the Efficacy of Intravenous Administration of Human Albumin Versus Saline Solution in Patien NCT07270874 | Fundacion Clinic per a la Recerca Biomédica | Phase 4 |
| Enrolling By Invitation | HCL001 Cell Injection for Decompensated Cirrhosis: A Phase I/II Trial NCT07488546 | Shanghai Huicun Medical Technology Co., Ltd. | Phase 1 / Phase 2 |
| Not Yet Recruiting | National Collaborative Centre for Hepatic Regenerative Medicine (NC-CHRM): Single vs Repeated Cycle of Granulo NCT07131280 | Institute of Liver and Biliary Sciences, India | N/A |
| Terminated | A Study to See if an Investigational Medicine Called VS-01 Can Help and How Safe it is in the Treatment of Pat NCT06987968 | Genfit | Phase 2 |
| Not Yet Recruiting | A Study to Predict Recompensation in Patients With Decompensated Cirrhosis Using Spleen Stiffness and Simple B NCT07087041 | Beijing Friendship Hospital | — |
| Recruiting | Carvedilol + Simvastatin vs. Carvedilol Alone for Cirrhosis and Cirrhotic Cardiomyopathy and Impact on Hepatic NCT06431919 | Post Graduate Institute of Medical Education and Research, Chandigarh | N/A |
| Recruiting | BCAA vs. Rifaximin in Patients With Cirrhosis for Secondary Prophylaxis of HE NCT06538077 | Post Graduate Institute of Medical Education and Research, Chandigarh | Phase 4 |
| Not Yet Recruiting | Fecal Microbiome Transplantation in Cirrhosis: Trial in Patients With Decompensated Cirrhosis NCT06533852 | Consorcio Centro de Investigación Biomédica en Red (CIBER) | Phase 3 |
| Recruiting | RTX001 Autologous Engineered Macrophages for Liver Cirrhosis NCT06823713 | Resolution Therapeutics Limited | Phase 1 / Phase 2 |
| Recruiting | Human Umbilical Cord-derived Mesenchymal Stem Cells for Decompensated Cirrhosis (MSC-DLC-2) NCT05224960 | Beijing 302 Hospital | Phase 2 |
| Recruiting | Hospital @ Home Model of Care for Cirrhosis NCT06396897 | Indiana University | N/A |
| Unknown | Incidence & Predictive Factors of Recompensation in Children With Decompensated Cirrhosis as Per the Baveno VI NCT06344611 | Institute of Liver and Biliary Sciences, India | — |
| Not Yet Recruiting | A Clinical Trial Evaluating the Safety, Tolerability, and Preliminary Efficacy of HCL001 Cell Injection (Homol NCT06306781 | RenJi Hospital | N/A |
| Unknown | Evaluation of Low-dose Albumin and Midodrine Versus Midodrine Alone in Outcome of Recurrent Ascites in Patient NCT06245590 | Institute of Liver and Biliary Sciences, India | N/A |
| Recruiting | Prospective Cohort Study of Complications and Outcomes in Cirrhosis NCT06374511 | Nanfang Hospital, Southern Medical University | — |
| Unknown | To Compare the Safety and Efficacy of Dapagliflozin Plus Metformin Versus Sitagliptin Plus Metformin for Treat NCT06147518 | Institute of Liver and Biliary Sciences, India | N/A |
| Recruiting | Trial Comparing Conventional Antibiotic Strategies Versus Regimens Guided by Epidemiological Surveillance in I NCT05783661 | Eva Bonfill | Phase 4 |
| Recruiting | Effect of IMO on Intestinal Microbiota Translocation in Cirrhosis NCT06134544 | Nanfang Hospital, Southern Medical University | N/A |
| Recruiting | CirrhoCare- Using Smart-phone Technology to Enhance Care and Access to Treatment for Cirrhosis NCT06223893 | University College, London | N/A |
| Unknown | Human Umbilical Cord-derived Mesenchymal Stem Cells for Decompensated Cirrhosis (MSC-DLC-1b) NCT05984303 | Beijing 302 Hospital | Phase 1 |
| Unknown | Rifaximin for Preventing Progression and Complications in Patients With Decompensated Liver Cirrhosis NCT05863364 | Xin Zeng | N/A |
| Completed | Coagulation Parameters With Albumin in Decompensated Cirrhosis (CoPA-D). NCT05937048 | Institute of Liver and Biliary Sciences, India | N/A |
| Unknown | Efficacy of High Dose Albumin Therapy in Improving Liver Transplant-free Survival in Patients With Acute Decom NCT05956197 | Institute of Liver and Biliary Sciences, India | — |
| Unknown | Albumin Infusion in Inpatients With Decompensated Cirrhosis NCT05719051 | Ruijin Hospital | — |
| Unknown | Rotational Thromboelastometry Versus Conventional Haemostatic Tests in Children With Decompensated Cirrhosis U NCT05734001 | Institute of Liver and Biliary Sciences, India | N/A |
| Unknown | Immune Profile, Neuronal Dysfunction, Metabolomics and Ammonia in Therapeutic Response of HE in ACLF NCT05421351 | Post Graduate Institute of Medical Education and Research, Chandigarh | — |
| Unknown | Human Umbilical Cord-derived Mesenchymal Stem Cells for Decompensated Cirrhosis (MSC-DLC-1) NCT05227846 | Beijing 302 Hospital | Phase 1 |
| Unknown | Re-compensation and Its Clinical Characteristics in HBV Decompensated Cirrhosis NCT05086536 | Beijing Friendship Hospital | — |
| Unknown | Treatment With Human Umbilical Cord-derived Mesenchymal Stem Cells for Decompensated Cirrhosis NCT05121870 | Beijing 302 Hospital | Phase 2 |
| Terminated | A Study for Evaluation of BIV201 to Reduce Ascites and Complications in Patients With Cirrhosis and Refractory NCT04112199 | BioVie Inc. | Phase 2 |
| Unknown | CirrhoCare in COVID-19: A Pilot, Remote, Home Monitoring Study in Advanced Cirrhosis NCT05045924 | Royal Free Hospital NHS Foundation Trust | — |
| Unknown | Avatrombopag in Patients With End-stage Liver Disease and Thrombocytopenia NCT04906083 | Tongji Hospital | Phase 4 |
| Unknown | Efficacy of Targeted And Response-Guided Albumin Therapy Versus Standard Medical Treatment In Outcomes Of Recu NCT04679571 | Institute of Liver and Biliary Sciences, India | N/A |
| Terminated | Primary Prophylaxis for Spontaneous Bacterial Peritonitis NCT04775329 | Changi General Hospital | Phase 2 / Phase 3 |
| Completed | New Prognostic Predictive Models of Mortality of Decompensated Cirrhotic Patients Waiting for Liver Transplant NCT03820271 | Assistance Publique - Hôpitaux de Paris | N/A |
| Completed | Efficacy of Combination of Midodrine With Propranolol in Preventing First Bleed in Decompensated Cirrhotics Wi NCT04208776 | Institute of Liver and Biliary Sciences, India | N/A |
| Unknown | Prospective Cohort Study of Disease and Outcomes in Cirrhosis NCT04422223 | Copenhagen University Hospital, Hvidovre | — |
| Completed | Effect of Liver MSCs in Blood of Patients With Liver Disease. NCT03632148 | Cliniques universitaires Saint-Luc- Université Catholique de Louvain | — |
| Terminated | Companion Protocol for Methacetin Breath Test (MBT) in Conatus Protocol IDN-6556-17 NCT03462576 | Meridian Bioscience, Inc. | — |
| Unknown | Emricasan, a Caspase Inhibitor, for Treatment of Subjects With Decompensated NASH Cirrhosis NCT03205345 | Conatus Pharmaceuticals Inc. | Phase 2 |
| Completed | Effect of Albumin Infusion on Oxidative Albumin Modification, Albumin Binding Capacity and Plasma Thiol Status NCT03214796 | Medical University of Graz | — |
| Unknown | Fecal Microbiota Transplantation for Decompensated Cirrhosis NCT03014505 | First Affiliated Hospital of Chengdu Medical College | Phase 1 / Phase 2 |
| Unknown | Injectable Collagen Scaffold™ Combined With HUC-MSCs Transplantation for Patients With Decompensated Cirrhosis NCT02786017 | Chinese Academy of Sciences | Phase 1 / Phase 2 |
| Completed | Management of Decompensated HCV Cirrhotic Patients NCT03547895 | Zagazig University | N/A |
| Completed | To Study The Incidence And Outcome Of Paracentesis Induced Circulatory Dysfunction in Decompensated Cirrhotics NCT02467322 | Institute of Liver and Biliary Sciences, India | N/A |
| Completed | A Study to Evaluate the Safety and Efficacy of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir With Ribavirin NCT02219477 | AbbVie | Phase 3 |
| Completed | A Trial to Study the Influence of Growth Factors on Bone Marrow and Hepatic Regeneration in Patients With Deco NCT01902511 | Institute of Liver and Biliary Sciences, India | N/A |
| Completed | Biomarkers for the Prognosis of Decompensated Alcoholic Liver Disease NCT01701687 | University of Nottingham | — |
| Completed | TIPS With 8- OR 10-mm Covered Stent for Preventing Variceal Rebleeding NCT01410591 | Air Force Military Medical University, China | N/A |
| Terminated | VSL#3 and Spontaneous Bacterial Peritonitis NCT01701297 | Nottingham University Hospitals NHS Trust | Phase 2 |
| Completed | The Effectiveness of L-ornithine-L-aspartate (LOLA) on Plasma Ammonia in Cirrhotic Patients After TIPS NCT01440829 | Air Force Military Medical University, China | Phase 2 / Phase 3 |
| Completed | Early TIPS With Polytetrafluoroethylene (PTFE) Covered Stents for Acute Variceal Bleeding in Patients With Adv NCT01370161 | Air Force Military Medical University, China | N/A |
| Completed | Transjugular Intrahepatic Portosystemic Shunt (TIPS) for Prevention of Variceal Rebleeding in Cirrhotic Patien NCT01326949 | Air Force Military Medical University, China | N/A |
| Unknown | Entecavir for Patients With Decompensated Hepatitis B Virus (HBV)-Related Cirrhosis NCT00663182 | Shanghai Changzheng Hospital | Phase 4 |
| No Longer Available | Replicor Compassionate Access Program NCT05683548 | Replicor Inc. | — |